|
|
|
| Office blood pressure combined with ambulatory blood pressure monitoring in hypertension diagnosis |
| DING Fang*, YU Wei, HU Shiyun, XUAN Cheng, YU Liuyan, CHEN Qifeng, FAN Minhua, LIU Qingmin, XU Xiaoling, YAN Jing
|
| The Provincial Center for Cardio-Cerebral-Vascular Disease, Zhejiang Hospital, Hangzhou, Zhejiang 310013, China |
|
|
|
|
Abstract Objective To evaluate the effects of office blood pressure(OBP)combined with ambulatory blood pressure monitoring(ABPM)on the diagnosis of hypertension. Methods The residents aged 35-79 years without hypertension history,whose casual OBP were 120~159 mm Hg/80~99 mm Hg,were enrolled from 4 communities of Hangzhou and Zhuji from 2015 to 2018. They were performed OBP measurements on other two days in 4 weeks and ABPM in a week. There were 2 criteria of OBP as elevated OBP on the first day or in 3 different days,and 4 criteria of ABPM as elevated mean BP in 24 hours, daytime, nighttime and either of the above time. Receiver operating characteristic(ROC)curve was employed to evaluate the effects of different OBP criteria combined with ABPM criteria on the diagnosis of masked hypertension(MH)and white-coat hypertension(WCH). Results Taking 3-day-OBP as a golden standard,the 1-day-OBP with 4 ABPM criteria had the areas under the ROC curve(AUC)of 0.79-0.81,sensitivity of 57.58%-62.77% and specificity of 100.00% in MH;had the AUC of 0.95-0.98,sensitivity of 100.00% and specificity of 88.96%-96.80% in WCH. The Kappa values were all less than 0.6,known as low consistency. Taking either time of ABPM as a golden standard,24 hours,daytime and nighttime ABPM criteria with OBP had the AUC of 0.90-0.92,sensitivity of 79.17%-83.90% and specificity of 100.00% in MH(all Kappa>0.6),when with 1-day-OBP,the Kappa values were all more than 0.8,known as high consistency;had the AUC of 0.95-1.00,sensitivity of 100.00% and specificity of 89.54%-99.37% in WCH,the Kappa values of daytime ABPM were all more than 0.6,known as high consistency. Conclusions If limited by options, 1-day-OBP could be used instead of 3-day-OBP for detection of WCH or exclusion of MH yet with less accuracy; 24 hours or daytime ABPM instead of either time of ABPM was reliable.
|
|
Received: 04 November 2019
Revised: 19 January 2020
Published: 12 May 2020
|
|
|
|
|
|
[1] 《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治, 2019, 19(1):1-44.
[2] WILLIAMS B, MANCIA G, SPIERING W, et al.2018 ESC/ESH Guidelines for the management of arterial hypertension[J]. Eur Heart J, 2018, 39(33): 3021-3104.
[3] KARIO K, SHIN J, CHEN C H, et al.Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia network[J]. J Clin Hypertens (Greenwich), 2019, 21(9): 1250-1283.
[4] 王继光, 吴兆苏, 孙宁玲, 等. 动态血压监测临床应用中国专家共识[J]. 中华高血压杂志, 2015, 23(8): 727-730.
[5] KANG Y Y, LI Y, HUANG Q F, et al.Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension[J]. J Hypertens, 2015, 33(8):1580-1587.
[6] TANG W, HU J, ZHANG H, et al.Kappa coefficient: a popular measure of rater agreement[J]. Shanghai Arch Psychiatry, 2015,27(1):62-67.
[7] PARATI G, STERGIOU G, O'BRIEN E, et al. European society of hypertension practice guidelines for ambulatory blood pressure monitoring[J]. J Hypertens, 2014,32(7): 1359-1366.
[8] HEAD G A, SHAW J E, DUNSTAN D W, et al.Hypertension, white-coat hypertension and masked hypertension in Australia: findings from the Australian Diabetes, Obesity, and Lifestyle Study 3[J]. J Hypertens, 2019, 37(8): 1615-1623.
[9] PEACOCK J, DIAZ K M, VIERA A J, et al.Unmasking masked hypertension:prevalence,clinical implications,diagnosis, correlates and future directions[J]. J Hum Hypertens, 2014, 28(9): 521-528.
[10] NASOTHIMIOU E G, TZAMOURANIS D, RARRA V, et al.Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension[J]. Hypertens Res, 2012,35(7):750-755.
[11] BRGULJAN-HITIJ J, THIJS L, LI Y, et al.Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure[J]. Am J Hypertens, 2014,27(7): 956-965.
[12] ZHANG D Y, GUO Q H, AN D W, et al.A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure[J]. J Hypertens, 2019,37(9): 1775-1785.
[13] PIERDOMENICO S D, PIERDOMENICO A M, COCCINA F, et al.Prognostic value of masked uncontrolled hypertension[J].Hypertension, 2018,72(4): 862-869.
[14] BOOTH J N, DIAZ K M, SEALS S R, et al.Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: The Jackson Heart Study[J]. Hypertension, 2016, 68(2):501-510.
[15] BANEGAS J R, RUILOPE L M, DE LA SIERRA A, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality[J]. N Engl J Med, 2018, 378(16): 1509-1520.
[16] ANSTEY D E, PUGLIESE D, ABDALLA M, et al.An update on masked hypertension[J]. Curr Hypertens Rep, 2017,19(12):94.
[17] KUSHIRO T, KARIO K, SAITO I, et al.Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension[J]. Hypertens Res, 2015, 38(3):178-185.
[18] SOVA M, SOVOVA E, HOBZOVA M, et al.The effect of continuous positive airway pressure therapy on the prevalence of masked hypertension in obstructive sleep apnea patients[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2015,159(2): 277-282.
[19] THAKKAR H V, POPE A, ANPALAHAN M.Masked hypertension: a systematic review[J]. Heart Lung Circ,2020,29(1):102-111.
[20] DOLAN E, JAMES K.Current approach to masked hypertension: from diagnosis to clinical management[J]. Clin Exp Pharmacol Physiol, 2017,44(12):1272-1278. |
|
|
|
